Clinical data on high risk medical devices should be made publicly availableBMJ 2011; 342 doi: https://doi.org/10.1136/bmj.d4162 (Published 30 June 2011) Cite this as: BMJ 2011;342:d4162
- Matthew Billingsley
Doctors and patients should have access to information on clinical trial data used to approve high risk medical devices so that they can make informed decisions about the devices they use, a WHO agency says.
In a report the Belgian Health Care Knowledge Centre recommends that the EU Medical Devices Directive should be adapted to require all manufactures of high risk medical devices to carry out “high quality randomised trials . . . with clinically relevant endpoints.”
The Belgian Health Care Knowledge Centre is part of WHO’s Health Evidence Network, which promotes the use of research evidence in health policy and health technology assessment. Its report places more emphasis on testing devices for their clinical effectiveness rather than the current focus on assessing …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial